198 Results
Sort By:
Published on August 22, 2024
A large study led by the Charité Medical University in Berlin shows no link between migraine and the risk of developing Parkinson’s disease in women aged 45 years and older. Writing in the journal Neurology, the investigators report that the risk of developing Parkinson’s disease over did not appear to…
Published on August 2, 2024
A large study of Parkinson’s disease genetics led by CENTOGENE, and the University of Rostock in Germany, shows approximately 15% of all cases of the disease are driven by genetic variants. As reported in the journal Brain, the researchers also confirmed that around 90% of individuals with a genetic form…
Published on July 23, 2024
Research by Weill Cornell Medicine has led to the development of a new model for understanding Parkinson’s disease progression and offers an innovative method for early detection of the condition. The findings, published today in Nature Communications, could ultimately lead to better management strategies and improved outcomes for those affected…
Published on January 3, 2024
Researchers at the University of Southern California (USC) reported this week they have newly identified a genetic mutation in a small protein that provides significant protection against the development of Parkinson’s disease. This new finding, reported in the journal Molecular Psychiatry, makes this beneficial variant an important target for developing…
Published on October 31, 2023
Researchers at the Barrow Neurological Institute have found that people living in regions that have median levels of air pollution have a 56 percent greater risk of developing Parkinson’s disease compared with those who live in areas with the lowest levels of air pollution. The study, which was conducted to…
Published on September 13, 2023
AXIM Biotechnologies, a developer of rapid tear drop-based diagnostics, announced today that has successfully developed a tear drop test that is the first rapid, non-invasive, point-of-care diagnostic for Parkinson’s disease (PD). The test detects abnormal alpha-synuclein—an important emerging biomarker of PD—found in a person’s tears. “Our proven expertise in developing…
Published on July 10, 2023
U.S. Parkinson’s disease patients being covered by Medicare health insurance are experiencing significant gaps and disparities in their care compared with non-Medicare patients, according to results from a Parkinson’s Foundation and University of Chicago study. As reported in the npj Parkinson’s Disease journal, 90% of U.S. Parkinson’s disease patients are…
Published on May 18, 2023
Research led by the French National Institute of Health and Medical Research (Inserm) in Paris suggests regular exercise could significantly reduce the risk of developing Parkinson’s disease. In the ongoing E3N cohort study of 95,000 women, lead researcher Alexis Elbaz, based at Inserm in Paris, and colleagues found that women…
Published on January 23, 2023
A recently discovered molecule which exists naturally in the sea sponge Lissodendoryx florida that may have therapeutic benefits for Parkinson’s disease, has been synthesized by organic chemists at UCLA, and in the process, may have uncovered a method to solve the challenge of chirality, which has hampered producing usable versions…
Published on September 14, 2022
New research from the brain research and advocacy non-profit Cohen Veterans Bioscience (CVB) has demonstrated that wearables data combined with an artificial intelligence (AI) algorithm can effectively identify people with Parkinson’s disease and those without. The results, published last week in the journal Sensors and supported by The Michael J.…
Published on August 26, 2022
Scientists in the Department of Electrical Engineering and Computer Science (EECS) at MIT and the MIT Jameel Clinic have developed an artificial intelligence (AI) tool that can detect early Parkinson’s disease by analyzing a person’s breathing patterns. The tool has the potential to significantly improve the diagnosis of this fast-growing…
Published on June 27, 2022
Research led by the Paris Brain Institute at the Sorbonne University shows that in some cases of Parkinson’s disease, the type of genetic mutations a person has could impact their disease prognosis. In an analysis of different patients with the condition, the researchers found that some genetic mutations improved prognosis,…
Published on May 9, 2022
Scientists have developed a new technique to enrich the degeneration of dopamine (DA) neurons from patients with Parkinson’s Disease (PD) and matched controls and profile their gene expression. Their study is published in the journal Nature Neuroscience. “It was known that cells in this area of the brain die, and…
Published on March 25, 2022
A new artificial intelligence (AI)-driven platform developed by researchers from the New York Stem Cell Foundation (NYSCF) Research Institute and Google Research successfully identified a cellular signal that differentiates skin cells of Parkinson’s disease patients from healthy controls. The platform uses a combination of automated cell culture, high-quality imaging, Cell…
Published on November 4, 2021
Research led by Northwestern University shows that damage to mitochondria in the brain can cause late-onset Parkinson’s symptoms in mice and that it is possible to boost the effects of levodopa treatment in these animals using a form of gene therapy. Mitochondria provide energy to cells around the body and…